These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1350900)

  • 1. Long-term outcome in chronic schizophrenia.
    Schwartz F; Terkelsen KG; Smith TE
    Arch Gen Psychiatry; 1992 Jun; 49(6):502-3. PubMed ID: 1350900
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative effectiveness of antipsychotic drugs.
    Adityanjee
    Am J Psychiatry; 2003 Mar; 160(3):590-1; author reply 592-3. PubMed ID: 12611852
    [No Abstract]   [Full Text] [Related]  

  • 3. Untreated psychosis and long-term outcome in schizophrenia.
    Waddington JL; Scully PJ
    Schizophr Bull; 1998; 24(1):34-5. PubMed ID: 9502545
    [No Abstract]   [Full Text] [Related]  

  • 4. Positive and negative symptoms in schizophrenia: where are the data?
    de Leon J; Simpson GM; Peralta V
    Biol Psychiatry; 1992 Mar; 31(5):431-4. PubMed ID: 1349829
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparing symptom response among antipsychotic medications in CATIE.
    Levine SZ; Rabinowitz J; Ascher-Svanum H; Faries DE; Lawson AH
    J Clin Psychopharmacol; 2013 Feb; 33(1):123-6. PubMed ID: 23288232
    [No Abstract]   [Full Text] [Related]  

  • 6. Violent behavior among schizophrenic patients.
    Graham LA; Thienhaus OJ; Somoya E
    Am J Psychiatry; 1990 Oct; 147(10):1383-5. PubMed ID: 1975992
    [No Abstract]   [Full Text] [Related]  

  • 7. Negative symptoms of schizophrenia are improved by paroxetine added to neuroleptics: a pilot study.
    Jockers-Scherübl M; Godemann F; Pietzcker A
    J Clin Psychiatry; 2001 Jul; 62(7):573. PubMed ID: 11488373
    [No Abstract]   [Full Text] [Related]  

  • 8. Early intervention with neuroleptics may decrease the long-term morbidity of schizophrenia.
    Wyatt RJ
    Schizophr Res; 1991 Oct; 5(3):201-2. PubMed ID: 1684719
    [No Abstract]   [Full Text] [Related]  

  • 9. Subjecting meta-analyses to closer scrutiny: Little support for differential efficacy among second-generation antipsychotics at equivalent doses.
    Tandon R; Nasrallah HA
    Arch Gen Psychiatry; 2006 Aug; 63(8):935-7; author reply 937-9. PubMed ID: 16894070
    [No Abstract]   [Full Text] [Related]  

  • 10. Olanzapine on trial.
    Mattes JA
    Am J Psychiatry; 1998 Jan; 155(1):153; author reply 153-5. PubMed ID: 9433359
    [No Abstract]   [Full Text] [Related]  

  • 11. The lifetime outcome and involuntary movements of schizophrenia never treated with neuroleptic drugs. Four rare cases in Ireland.
    Waddington JL; Youssef HA
    Br J Psychiatry; 1990 Jan; 156():106-8. PubMed ID: 1967543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lower-dose therapy with traditional neuroleptics in chronically hospitalized schizophrenic patients.
    Smith RC
    Arch Gen Psychiatry; 1994 May; 51(5):427-9. PubMed ID: 7910013
    [No Abstract]   [Full Text] [Related]  

  • 13. The costs of drugs for schizophrenia.
    Freedman R; Carpenter WT; Davis JM; Goldman HH; Tamminga CA; Thomas M
    Am J Psychiatry; 2006 Dec; 163(12):2029-31. PubMed ID: 17151146
    [No Abstract]   [Full Text] [Related]  

  • 14. [Deficit schizophrenias].
    Puech AJ
    Encephale; 1996 Jun; 22 Spec No 2():1. PubMed ID: 8767033
    [No Abstract]   [Full Text] [Related]  

  • 15. [Better prognosis due to new treatment approaches. Therapy of schizophrenia in 2002].
    Janssen B; Gaebel W
    MMW Fortschr Med; 2002 May; Suppl 2():72-6, 78. PubMed ID: 12070858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prodromal signs of schizophrenic relapse.
    Herz MI; Simon JC
    Am J Psychiatry; 1986 Jan; 143(1):115-6. PubMed ID: 2867689
    [No Abstract]   [Full Text] [Related]  

  • 17. Management of treatment refractory schizophrenia.
    Morrison DP
    Br J Psychiatry Suppl; 1996 Dec; (31):15-20. PubMed ID: 8968651
    [No Abstract]   [Full Text] [Related]  

  • 18. Definitions of response and remission in schizophrenia: recommendations for their use and their presentation.
    Leucht S; Davis JM; Engel RR; Kissling W; Kane JM
    Acta Psychiatr Scand Suppl; 2009; (438):7-14. PubMed ID: 19132961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Depressive symptoms in schizophrenia].
    Gerard A
    Encephale; 1998 Jul; 24 Spec No 1():24-6. PubMed ID: 9809250
    [No Abstract]   [Full Text] [Related]  

  • 20. Schizophrenia, violence, clozapine and risperidone: a review. The Special Hospitals Treatment Resistant Schizophrenia Research Group.
    Br J Psychiatry Suppl; 1996 Dec; (31):21-30. PubMed ID: 8968652
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.